News

Filter

Current filters:

Rare diseasesLicensing

1 to 9 of 87 results

Alizé Pharma acquires exclusive worldwide rights for new peptide to tackle bone diseases

03-12-2014

Alizé Pharma, a group of privately-held biopharmaceutical companies specialized in the development of…

Alize PharmaLicensingPharmaceuticalRare diseasesUSA

Dicerna licenses rights to Tekmira technology

Dicerna licenses rights to Tekmira technology

18-11-2014

US RNAi therapeutics specialist Dicerna Pharmaceuticals has entered a licensing agreement for to use…

BiotechnologyDCR-PH1Dicerna PharmaceuticalsLicensingRare diseasesTekmira PharmaceuticalsUSA

Akashi gets rights to novel DMD treatment from Tonus

Akashi gets rights to novel DMD treatment from Tonus

15-09-2014

US clinical-stage biopharma firm Akashi Therapeutics has acquired global rights to GsMTx-4, a small molecule…

Akashi TherapeuticsGlobalGsMTx-4LicensingPharmaceuticalRare diseasesTonus Therapeutics

THERAMetrics and Centurion Pharma collaboration in rare diseases area

THERAMetrics and Centurion Pharma collaboration in rare diseases area

05-08-2014

Switzerland’s THERAMetrics holding and Turkish drugmaker Centurion Pharma plan to cooperate in the…

aviptadilCenturion PharmaIdiopathic pulmonary fibrosisLicensingPharmaceuticalRaffaele PetroneRare diseasesSarcoidosisTHERAMetricsTurkey

Roche joins forces with AmorChem on Steinert’s disease research

Roche joins forces with AmorChem on Steinert’s disease research

29-07-2014

Swiss drug major Roche and AmorChem, a Canadian venture capital firm investing in life science projects,…

AmorChemCanadaEnabling technologyEuropean UnionLicensingMajorMuscular dystrophyMyotonic dystrophyPharmaceuticalRare diseasesResearchRocheSwitzerland

Retrophin acquires US Thiola rights from Mission Pharmacal

Retrophin acquires US Thiola rights from Mission Pharmacal

30-05-2014

US drugmaker Retrophin has entered into a license agreement with Mission Pharmacal, a private company…

LicensingMission PharmacalNephrology and HepatologyPharmaceuticalRare diseasesRetrophinThiolaUSA

uniQure signs up Medison to distribute Glybera in Israel

uniQure signs up Medison to distribute Glybera in Israel

29-05-2014

Netherlands-based human gene therapy firm uniQure has entered an exclusive distribution agreement with…

BiotechnologyGlyberaLicensingMedison PharmaRare diseasesRest of the WorlduniQure

1 to 9 of 87 results

COMPANY SPOTLIGHT

Menarini

Back to top